Agios Pharmaceuticals (AGIO) shares were up 27% in recent pre-market trade after saying this weekend that data from a study on the AG-221 drug in patients with advanced blood cancers showed “promising” clinical activity. AGIO is in the upper half of the 52-week range between $15.77 and $49.79. The purpose of the phase 1 program…
Freescale Semiconductor Aggreed to Buy the Comcerto CPE
Freescale Semiconductor (FSL) reported that it has agreed to buy the processor business arm of Mindspeed Technologies.
Peregrine Pharmaceuticals (PPHM) shares was up 7% in Pre-Market
The stock price of Peregrine Pharmaceuticals (PPHM) was up 7% in Pre-Market.
Mattel Has Been Downgraded by analysts
Mattel, Inc. (MAT) price target has been reduced from $40 to $33 a share.
Response Genetics Stock Jumps as Filing Shows Becker Drapkin Pared Stake
Response Genetics (RGDX) shares climbed in Monday’s pre-market session, after a late-Friday regulatory filing showed activist investor Becker Drapkin cut its stake last week in the developer of clinical diagnostic tests for cancer. RGDX was up 8.5% at $1.40 in recent pre-market trading, in a 52-week range of $1.09 to $2.93. The filing showed Becker…
Foster Wheeler Signed a New Contract
Foster Wheeler (FWLT) reported that it signed a contract with Marubeni Corp.
Pfizer Reports Good Results related to treatment of Breast Cancer
Pfizer (PFE) has reported the results of one of its studies related to treatment of the cancer.
Laclede Group Buys Alabama Gas
Laclede Group (LG) which is one of the leading utility companies has reported that it agreed to buy natural-gas utility Alabama Gas.